FOSHAN PHARMA CP.,LTD– Our company is pleased to officially launch its high-quality Tranexamic Acid Injection, a professional hemostatic drug designed to meet diverse clinical hemostasis needs. As a synthetic lysine derivative, this product relies on advanced production technology and strict quality control, providing reliable support for medical institutions and related partners. We sincerely welcome all customers to learn about and purchase our products.
Tranexamic Acid Injection is a potent antifibrinolytic hemostatic agent with a clear mechanism: it competitively binds to plasmin and plasminogen, inhibiting fibrin dissolution to achieve effective hemostasis. Compared with similar products, it boasts strong efficacy, long duration and wide applicability, and can penetrate the blood-brain barrier, making it more effective for central nervous system bleeding.
Available in specifications of 2ml:0.1g, 5ml:0.25g and 5ml:0.5g, it applies to various bleeding caused by primary fibrinolysis, post-surgical bleeding of specific organs, thrombolytic drug overdose, and auxiliary treatment of hemophilia. It can also treat hereditary angioedema.
Adhering to the "quality first" principle, our company strictly follows national pharmaceutical standards, with a complete quality control system from raw material selection to product inspection. The product has passed strict tests, with low adverse reaction rates, ensuring safety and reliability.
As a professional pharmaceutical enterprise, we provide professional technical support and efficient after-sales service. We sincerely invite all sectors to pay attention to our Tranexamic Acid Injection, learn more via our official website or sales team, and choose our high-quality hemostatic solutions.
